HLA-B.md
... ...
@@ -27,16 +27,8 @@ timeline
27 27
28 28
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
29 29
30
-|Entity|source |frequency (%)|
31
-|:------:|:---------------------:|:-------------:|
32
-|BL |GAMBL genomes+capture| 3.46 |
33
-|BL |Thomas cohort | 3.80 |
34
-|BL |Panea cohort | 5.00 |
35
-|DLBCL |GAMBL genomes | 9.18 |
36
-|DLBCL |Schmitz cohort |16.38 |
37
-|DLBCL |Reddy cohort | 1.20 |
38
-|DLBCL |Chapuy cohort |10.68 |
39
-|FL |GAMBL genomes | 3.46 |
30
+[[include:DLBCL_HLA-B.md]]
31
+[[include:FL_HLA-B.md]]
40 32
41 33
## Mutation pattern and selective pressure estimates
42 34
HLA-C.md
... ...
@@ -27,12 +27,7 @@ timeline
27 27
28 28
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
29 29
30
-|Entity|source |frequency (%)|
31
-|:------:|:--------------:|:-------------:|
32
-|DLBCL |GAMBL genomes |3.63 |
33
-|DLBCL |Schmitz cohort|5.53 |
34
-|DLBCL |Reddy cohort | NA |
35
-|DLBCL |Chapuy cohort |4.70 |
30
+[[include:DLBCL_HLA-C.md]]
36 31
37 32
## Mutation pattern and selective pressure estimates
38 33
HLA-DMB.md
... ...
@@ -16,15 +16,7 @@ HLA-DMB, along with HLA-DMA, plays a critical role in the proper functioning of
16 16
17 17
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
18 18
19
-|Entity|source |frequency (%)|
20
-|:------:|:---------------------:|:-------------:|
21
-|BL |GAMBL genomes+capture| NA |
22
-|BL |Thomas cohort |0.00 |
23
-|BL |Panea cohort | NA |
24
-|DLBCL |GAMBL genomes |3.82 |
25
-|DLBCL |Schmitz cohort |5.11 |
26
-|DLBCL |Reddy cohort | NA |
27
-|DLBCL |Chapuy cohort |1.71 |
19
+[[include:DLBCL_HLA-DMB.md]]
28 20
29 21
## Mutation pattern and selective pressure estimates
30 22